Advisor Group, Inc. - ELOXX PHARMACEUTICALS INC ownership

ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 42 filers reported holding ELOXX PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Advisor Group, Inc. ownership history of ELOXX PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2019$91,000
+62.5%
12,3590.0%0.00%
Q3 2019$56,000
-54.5%
12,3590.0%0.00%
-100.0%
Q2 2019$123,000
+373.1%
12,359
+458.0%
0.00%
Q1 2019$26,000
-3.7%
2,2150.0%0.00%
Q4 2018$27,000
-28.9%
2,2150.0%0.00%
Q3 2018$38,000
-61.6%
2,215
-61.9%
0.00%
-100.0%
Q2 2018$99,0005,8150.00%
Other shareholders
ELOXX PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 1,930,092$1,363,0000.55%
AMERICAN FINANCIAL GROUP INC 1,480,000$1,045,0000.29%
Vanguard Capital Wealth Advisors 158,900$111,0000.08%
Anson Funds Management LP 553,652$391,0000.04%
Nantahala Capital Management 894,659$632,0000.02%
MENORA MIVTACHIM HOLDINGS LTD. 2,094,208$1,479,0000.02%
Harel Insurance Investments & Financial Services Ltd. 1,176,401$831,0000.02%
Atom Investors LP 113,151$80,0000.01%
Virtu Financial LLC 130,270$91,0000.01%
Altshuler Shaham Ltd 1,157,540$828,0000.01%
View complete list of ELOXX PHARMACEUTICALS INC shareholders